Physician

Jason So Go, MD

According to 2025 Medicare claims, Jason Go, MD (NPI: 1447475637) practices cardiology in the Grand Forks, ND-MN market, with the plurality of this provider's patient population coming from Grand Forks, ND. This provider's primary affiliated billing organization is SANFORD MEDICAL CENTER FARGO (NPI: 1184917924; TIN: 450226909) and primary practice location at 58104-7927. Go is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), Caravan Health ACO 50 LLC (ACO ID: A5160), CVS ACO (ACO ID: A5407), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Go's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,657 traditional Medicare patients, billed 3,865 HCPCS/CPT codes, and received $175,539 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,506 prescription claims across 291 beneficiaries totaling $193,143 in drug costs, led by Repatha Sureclick (Evolocumab). 2023 DME data shows 12 claims. Open Payments data shows 61 records totaling $122,266. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $95,243 and ending at $193,143. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $1,410 to $1,187.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,542	3,424	$173,608
2016	1,589	3,926	$192,143
2017	2,039	4,676	$227,111
2018	2,235	5,053	$242,295
2019	2,515	5,496	$289,994
2020	2,814	7,463	$301,755
2021	2,352	6,521	$327,613
2022	2,386	5,792	$264,846
2023	2,303	6,015	$249,840
2024	1,657	3,865	$175,539

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	342	2,951	$95,243
2016	377	3,152	$136,797
2017	541	3,704	$279,853
2018	572	4,235	$413,522
2019	584	3,809	$370,139
2020	495	2,489	$179,908
2021	375	1,539	$144,830
2022	297	1,480	$185,306
2023	336	1,589	$208,931
2024	291	1,506	$193,143

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	24	$1,410
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	12	$1,095
2023	N/R	12	$1,187
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	167	182	$66
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	497	503	$49
99152	Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes	173	201	$9
93793	Anticoagulant management of patient taking warfarin	275	444	$6
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	439	518	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Repatha Sureclick	Evolocumab	50	3,164	$57,969
Eliquis	Apixaban	57	2,370	$44,714
Praluent Pen	Alirocumab	25	1,484	$23,834
Entresto	Sacubitril/Valsartan	18	932	$16,629
Jardiance	Empagliflozin	17	510	$10,870

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	57	$1,350	ShockWave Medical, Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	4	$120,916	Novartis Pharmaceuticals Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jason So Go, MD?

Tedicare shows public-source Medicare data for Jason So Go, MD (NPI 1447475637), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jason So Go, MD have ACO affiliation data?

Jason So Go, MD is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), CVS ACO (MSSP, ACO ID A5407), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Jason So Go, MD?

Jason So Go, MD is linked to SANFORD MEDICAL CENTER FARGO (billing NPI 1184917924) in the available physician profile data.

Does Jason So Go, MD have Open Payments data?

Jason So Go, MD has 61 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.